AZ funded non-clinical PhD Studentship (Fixed Term)

AZ funded non-clinical PhD Studentship (Fixed Term) in Partitioning the genetic effects of obesity on future comorbidity risks

Applications are invited for 4-year PhD studentship (starting October 2025) based in the University of Cambridge's Cardiovascular Epidemiology Unit and the new AstraZeneca Discovery Centre at Cambridge. The student will be working on a collaborative project entitled "Partitioning the effects of high body mass index on risk of future comorbidities", jointly supervised by Dr Samuel Lambert (Assistant Professor of Health Data Science, University of Cambridge) and Dr Xiao Jiang (Senior Data Scientist, Centre for Genomics Research, AstraZeneca).

High body mass index (BMI) is a highly prevalent modifiable risk factor for many cardiometabolic and renal diseases, but also multiple cancers and neurodegenerative disorders. BMI remains a crude measure of risk as not all people with high BMI get all possible comorbidities. This motivates research into the possibility of predicting which specific comorbidities of high BMI (obesity) an individual is most likely to develop.

The project will harness large-scale human genetic resources with deep phenotyping data (e.g., UK Biobank, INTERVAL, BELIEVE) to interrogate the molecular aetiology of BMI and identify discrete axes of risk that may inform more personalized medicine and identify therapeutic targets. The student will employ genomic and computational approaches (e.g. GWAS, polygenic scores, Mendelian randomization, machine learning methods) integrating genetic data, health records, and multi-omics data from blood.

Candidate Applicants should hold (or have achieved by the start date) a first or upper second-class degree from a UK university, or an equivalent standard from an overseas university, and preferably a Master's degree (or equivalent), in a relevant subject (e.g. epidemiology, (bio)statistics, genomics, bioinformatics). They should have strong quantitative skills, experience with programming (e.g., R, Python, etc), and enjoy working in a team environment.

The position is open to UK citizens or overseas students who meet the UK residency requirements (home fees). International students who are able to cover the additional costs of overseas tuition fees through scholarships or funding schemes will also be considered (self-funding is not permitted).

See for full details of entrance requirements and additional funding sources.

Funding Full funding covering the University Composition Fee (home tuition and college fees) and a stipend of £21,500 per annum are provided for the 4-year studentship.

Research environment and training The student will primarily be based in the BHF Cardiovascular Epidemiology Unit (CEU, ) at the Victor Phillip Dahdaleh Heart and Lung Research Institute (HLRI, ). The HLRI is across the road from AstraZeneca, allowing for work across both sites. The student will benefit from a collaborative environment that promotes equality, diversity and inclusion, and values all individuals. There are no coursework requirements, but taught modules and lectures in relevant subjects are available within the CEU and wider University.

Course details: PhD in Public Health & Primary Care (Full-time) Start Date: October 2025Supervisor(s): Dr Samuel LambertResearch Title: AZ funded non-clinical PhD Studentship ¿ Obesity and comorbiditiesReference: RH43284

Interview and Selection process Deadline for applications is 20th November 2024Shortlisted candidates will be invited to interview week commencing 2nd December 2024, and be notified of the outcome soon after.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.The University has a responsibility to ensure that all employees are eligible to live and work in the UK.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.